Company Biotech Acquisition Company

BIOT

KYG1125A1085

Managers

Members of the board

Share class

Company contact information

Sector

Sector Shell Companies

Inactive Instrument

Biotech Acquisition Company is a blank check company. The Company is created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more businesses. The Company focuses for a target business in the healthcare sector. It has no operations and has no revenues.

Managers	Title	Age	Since
Michael Shleifer CEO	Chief Executive Officer	49	-
Thomas Fratacci DFI	Director of Finance/CFO	46	01/20/01
Ivan Jarry COO	Chief Operating Officer	45	01/20/01
Albert F. Hummel CIO	Chief Investment Officer	78	01/20/01
Tanguy Serra PRN	Corporate Officer/Principal	45	03/20/03

Members of the board	Title	Age	Since
Albert F. Hummel CIO	Chief Investment Officer	78	01/20/01
Bruno Montanari BRD	Director/Board Member	49	25/21/25
Paul D. Bernard BRD	Director/Board Member	55	25/21/25
Michael Shleifer CEO	Chief Executive Officer	49	-
Aaron Kim BRD	Director/Board Member	53	25/21/25

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	5,750,000	0	0	80.00 %
Stock B	1	23,000,000	23,000,000 ( 100.00 %)	0

Biotech Acquisition Co.

545 West 25th Street 20th floor

10001, New York

http://bioacq.com

address Biotech Acquisition Company(BIOT)

Financials

Holding Companies

Holding Companies

Investment Holding Companies

Shell Companies

	1st Jan change	Capi.
TRUMP MEDIA & TECHNOLOGY GROUP CORP.	+190.94%	6.96B
CHURCHILL CAPITAL CORP VII	+2.14%	982M
APPLE ISPORTS GROUP, INC.	+41.91%	872M
PERELLA WEINBERG PARTNERS	+26.98%	830M
ARES ACQUISITION CORPORATION II	+1.72%	664M
E7 GROUP	+5.92%	642M
DA ZHONG TRADING GROUP HOLDING COMPANY	-.--%	600M
ADMIRAL ACQUISITION LIMITED	+3.61%	503M
CAPITOL INVESTMENT CORP. VII	-.--%	500M

Shell Companies